<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Microdose Radiopharmaceutical Diagnostic Drugs: Nonclinical Study Recommendations; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Microdose Radiopharmaceutical Diagnostic Drugs: Nonclinical Study Recommendations; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2018-08-21 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Microdose Radiopharmaceutical Diagnostic Drugs: Nonclinical Study Recommendations." This guidance is intended to assist sponsors of microdose radiopharmaceutical diagnostic drugs on the nonclinical studies recommended to support human clinical trials and marketing applications. This guidance finalizes the draft guidance of the same name issued on September 13, 2017.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2018-17961</p>
    <p><strong>Publication Date:</strong> 2018-08-21</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2018/08/21/2018-17961/microdose-radiopharmaceutical-diagnostic-drugs-nonclinical-study-recommendations-guidance-for">https://www.federalregister.gov/documents/2018/08/21/2018-17961/microdose-radiopharmaceutical-diagnostic-drugs-nonclinical-study-recommendations-guidance-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2018-17961</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
